Histogen Inc HSTO:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 05/17/24 EDT
0.21quote price arrow up+0.009 (+4.4776%)
Volume
287
52 week range
0.05 - 1.05
Loading...
  • Open0.21
  • Day High0.21
  • Day Low0.21
  • Prev Close0.201
  • 52 Week High1.05
  • 52 Week High Date05/22/23
  • 52 Week Low0.05
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap897,069.573
  • Shares Out4.27M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta0.83
  • YTD % Change-31.75

KEY STATS

  • Open0.21
  • Day High0.21
  • Day Low0.21
  • Prev Close0.201
  • 52 Week High1.05
  • 52 Week High Date05/22/23
  • 52 Week Low0.05
  • 52 Week Low Date04/19/24
  • Market Cap897,069.573
  • Shares Out4.27M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta0.83
  • YTD % Change-31.75

RATIOS/PROFITABILITY

  • EPS (TTM)-2.90
  • P/E (TTM)-0.07
  • Fwd P/E (NTM)-0.10
  • EBITDA (TTM)-11.917M
  • ROE (TTM)-108.97%
  • Revenue (TTM)18,999.999
  • Gross Margin (TTM)21.05%
  • Net Margin (TTM)-65,173.68%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Histogen Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Histogen Inc. is a clinical-stage therapeutics company. The Company is focused on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to restore immune function. Its product candidates include emricasan, CTS-2090 and CTS-2096. It develops emricasan for acute bacterial skin and skin structure infections (ABSSSI) as well evaluating its use for other infectious diseases. Its pipeline also...
Daniel Kisner M.D.
Non-Executive Chairman of the Board
Susan Knudson
President, Chief Executive Officer, Chief Financial Officer
Address
10655 SORRENTO VALLEY ROAD, SUITE 200
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
ALLR
Allarity Therapeutics Inc
0.639-0.0338-5.0238%
BNTC
Benitec Biopharma Inc
9.49+0.02+0.21%
CFRXQ
ContraFect Corp
0.0165+0.0015+10.00%
CALA
Calithera Biosciences Inc
0.02UNCHUNCH
AMBS
Amarantus Bioscience Holdings Inc
0.0001UNCHUNCH